Alanna Wright
Psychiatric/Mental Health · Jackson, MSNPI 1073840021
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $42,750 of the $58,449 with a category attached, or 73.1%. AbbVie accounts for 98.6% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $47,015, more than ten times the $227 reported in 2021. Among psychiatric/mental health clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $286.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$58K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$208
- Axsome Therapeutics, Inc.$143
- Teva Pharmaceuticals USA, Inc.$124
- Otsuka America Pharmaceutical, Inc.$84
- Alkermes, Inc.$79
- plus $187 from 5 others
What the payments were for
- Speaking & faculty fees$42,75073%
- Travel & lodging$12,83722%
- Food & beverage$2,7685%
- Education$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 167 | $57,625 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $208 |
| Axsome Therapeutics, Inc. | 6 | $143 |
| Teva Pharmaceuticals USA, Inc. | 6 | $124 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Alkermes, Inc. | 4 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Neurocrine Biosciences, Inc. | 2 | $51 |
| Johnson & Johnson | 2 | $36 |
| Lundbeck LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$55,579
How this compares
$58,449 in reported general payments places this provider in the 95th percentile of 486 psychiatric/mental health providers in Mississippi.
See all psychiatric/mental health providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 33 | $91,053 |
| Invega SustennaPaliperidone Palmitate | 31 | $86,069 |
| VraylarCariprazine Hcl | 58 | $78,983 |
| FanaptIloperidone | 24 | $57,399 |
| Lurasidone Hcl | 78 | $36,237 |
| TrintellixVortioxetine Hydrobromide | 14 | $7,996 |
| Aripiprazole | 106 | $4,399 |
| Paliperidone ErPaliperidone | 16 | $4,300 |
| Asenapine Maleate | 13 | $3,326 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 22 | $3,298 |
| Haloperidol Decanoate | 74 | $2,903 |
| Haloperidol | 67 | $2,228 |
| Bupropion XlBupropion Hcl | 121 | $2,182 |
| Amitriptyline Hcl | 80 | $1,543 |
| Divalproex Sodium ErDivalproex Sodium | 47 | $1,408 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $84 | $91,05333 claims |
| Johnson & JohnsonInvega Sustenna | $36 | $86,06931 claims |
| AbbVieVraylar | $57,625 | $78,98358 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $67 | $57,39924 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $13 | $7,99614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 486 psychiatric/mental health providers in Mississippi.
Other psychiatric/mental health in Jackson
- Belinda EdwardsJackson$29K
- Kimberly KelleyJackson$11K
- Tyrah HickmanJackson$5K
- Min Jung KangJackson$5K
- Adriane HarveyJackson$5K
- Brandy RutlandJackson$4K
- Ashley KarelVicksburg$129K
- Amanda HamCorinth$64K
- Amanda ThomasTupelo$41K
- Amelia KelleyMeridian$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.